[HTML][HTML] Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial
Objective To assess the safety and feasibility of allogeneic human umbilical cord blood (hUCB)-derived
mesenchymal stem cell (MSC) transplantation in preterm infants. Study design In …
mesenchymal stem cell (MSC) transplantation in preterm infants. Study design In …
[HTML][HTML] Two-year follow-up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia
Objective To determine the long-term safety and outcomes of mesenchymal stem cells (MSCs)
for bronchopulmonary dysplasia in premature infants enrolled in a previous phase I …
for bronchopulmonary dysplasia in premature infants enrolled in a previous phase I …
Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage
Background and Purpose— Severe intraventricular hemorrhage (IVH) in premature infants
and the ensuing posthemorrhagic hydrocephalus cause significant mortality and neurological …
and the ensuing posthemorrhagic hydrocephalus cause significant mortality and neurological …
Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta‐ defensin‐ 2 via toll‐ like receptor 4 signalling
DK Sung, YS Chang, SI Sung, HS Yoo… - Cellular …, 2016 - Wiley Online Library
Recently, we demonstrated that intratracheal transplantation of human umbilical cord blood‐
derived mesenchymal stem cells (MSCs) attenuates Escherichia (E) coli‐ induced acute …
derived mesenchymal stem cells (MSCs) attenuates Escherichia (E) coli‐ induced acute …
[HTML][HTML] Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung …
We previously reported the role of vascular endothelial growth factor (VEGF) secreted by
mesenchymal stem cells (MSCs) in protecting against neonatal hyperoxic lung injuries. …
mesenchymal stem cells (MSCs) in protecting against neonatal hyperoxic lung injuries. …
[HTML][HTML] MERS-CoV infection in a pregnant woman in Korea
Middle East respiratory syndrome (MERS) is a lethal respiratory disease—caused by MERS-coronavirus
(MERS-CoV) which was first identified in 2012. Especially, pregnant women …
(MERS-CoV) which was first identified in 2012. Especially, pregnant women …
[HTML][HTML] Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants
SI Sung, YS Chang, JY Chun, SA Yoon, HS Yoo… - The Journal of …, 2016 - Elsevier
Objective To determine whether a nonintervention approach for treating hemodynamically
significant patent ductus arteriosus (PDA) is associated with decreased mortality and/or …
significant patent ductus arteriosus (PDA) is associated with decreased mortality and/or …
[HTML][HTML] Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury
Intratracheal transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem
cells (MSCs) attenuates the hyperoxia-induced neonatal lung injury. The aim of this study …
cells (MSCs) attenuates the hyperoxia-induced neonatal lung injury. The aim of this study …
Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial
We previously demonstrated that transplanting mesenchymal stem cells (MSCs) improved
recovery from brain injury induced by severe intraventricular hemorrhage (IVH) in newborn …
recovery from brain injury induced by severe intraventricular hemorrhage (IVH) in newborn …
[HTML][HTML] Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy
Though hypothermia is the only clinically available treatment for neonatal hypoxic-ischemic
encephalopathy (HIE), it is not completely effective in severe cases. We hypothesized that …
encephalopathy (HIE), it is not completely effective in severe cases. We hypothesized that …